About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Repeatability of OCT and IV-US in Pulmonary Arterial Hypertension

NCT03105934·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Hospital Universitari Vall d'Hebron Research Institute

Age

18–80

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

With confirmed diagnosis of PAH Group 1 according to the ESC/ERS Guidelines
With severe disease, defined as Class II- III of the modified WHO functional classes in the ESC/ERS Guidelines

You may not be if

That according to investigator criteria cannot participate in the trial

The record

StatusCompleted

PhaseNo phase

Taking part20

StartedApr 2016

UpdatedFeb 12, 2018

Conditions

Pulmonary Arterial Hypertension

Where1

Hospital Vall d'Hebron
Barcelona, Spain

Clareo Health | Repeatability of OCT and IV-US in Pulmonary Arterial Hypertension